Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism

COVID-19 is caused by Severe Acute Respiratory Syndrome Coronavirus-2, which has infected over thirty eight million individuals worldwide. Emerging evidence indicates that COVID-19 patients are at a high risk of developing coagulopathy and thrombosis, conditions that elevate levels of D-dimer. It is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Abu-Farha, Mohamed, Al-Sabah, Salman, Hammad, Maha M., Hebbar, Prashantha, Channanath, Arshad Mohamed, John, Sumi Elsa, Taher, Ibrahim, Almaeen, Abdulrahman, Ghazy, Amany, Mohammad, Anwar, Abubaker, Jehad, Arefanian, Hossein, Al-Mulla, Fahd, Thanaraj, Thangavel Alphonse
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7756688/
https://ncbi.nlm.nih.gov/pubmed/33362545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.587451
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados